Ibrance 125 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0MB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,110
Award facts
- Contract value 100% obligated
- $17,110.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,110.42 to AmerisourceBergen Drug Corp for IBRANCE 125 mg tablets (quantity 7) on January 15, 2026, with a completion date of February 6, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. IBRANCE is a prescription oncology medication used in cancer treatment, and this delivery supports the federal government's pharmaceutical supply needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This primary IDC vehicle enables the contractor to supply a comprehensive range of pharmaceutical products, medical supplies, specialty medications, and related medical commodities to support military healthcare programs globally, including delivery to Defense Health Agency facilities, the U.S. Coast Guard, and other federal medical institutions. As a leading pharmaceutical distributor, AmerisourceBergen/Cencora has demonstrated consistent capability to fulfill federal procurement requirements for essential medications and medical supplies through open competition.
Quick answers
Who was awarded contract SPE2DR26FR0MB?
SPE2DR26FR0MB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FR0MB worth?
The government has obligated $17,110 on SPE2DR26FR0MB.
Is contract SPE2DR26FR0MB an order under another contract?
Yes. SPE2DR26FR0MB is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0MB competed?
The extent of competition for SPE2DR26FR0MB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award